Optimizing outcomes for patients with nonmetastatic pancreatic cancer Feb. 06, 2023 Overview Show transcript Overview A multidisciplinary team from Mayo Clinic Comprehensive Cancer Center discuss the best options to optimize outcomes for patients with nonmetastatic pancreatic cancer. Experts include Mark J. Truty, M.D., M.S., surgical oncologist, Christopher L. Hallemeier, M.D., radiation oncologist, and Ajit H. Goenka, M.D., radiologist. The conversation was moderated by Tanios S. Bekaii-Saab, M.D., medical oncologist. These pancreatic cancer experts discussed disease staging, measuring for optimal treatment response and the novel curative intent surgical options available for patients today. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticle3 factors associated with improved outcomes for individuals with pancreatic ductal adenocarcinomaArticleEvaluating the safety and diagnostic accuracy of endoscopic fine-needle aspiration for detection of extravascular migratory metastases in the pancreas VID-20544638 Medical Professionals Optimizing outcomes for patients with nonmetastatic pancreatic cancer